Kris Siezen

ESTP Congress
cl.siezen@cbg-meb.nl
,

Christine (Kris) Siezen is a senior non-clinical assessor at the Medicines Evaluation Board (MEB) of the Netherlands with a research PhD focusing on cancer pathways. Her experience as an assessor, and application of ICH safety guidelines, goes back 17 years with specific focus on carcinogenicity studies and their value in risk assessment of human medicines. In addition she is a long-standing member of EMA’s Non-Clinical Working party and since ICH S1B(R1) has come into effects, she is regulatory chair of the Implementing Working Group (IWG) for this guideline for Europe.